The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.
and Legend Biotech’s Carvykti (ciltacabtagene autoleucel), Novartis’s Kymriah (tisagenlecleucel), and Gilead and Kite’s Yescarta’s Tecartus (brexucabtagene autoleucel) and Yescarta (axicabtagene ciloleucel). ... Companies including Gilead, BMS,
The partnership centres around Epic Bio’s proprietary gene regulation platform. Kite, a Gilead company, and Epicrispr Biotechnologies have entered into a research collaboration and licensing agreement aimed at developing new
With support from akt health. Reshaping the Conversation for Gilead’s Established Products (EP) Portfolio. ... By Gilead. With support from OPEN Health. Shape the Change: A Resource built with, by and for the Sickle Cell Community.
Gilead Sciences has announced that its COVID-19 treatment Veklury (remdesivir) has been recommended by the European Medicines Agency’s human medicines committee for use in patients with mild-to-severe ... Earlier this year, Gilead presented positive
Other Gold winners were Alliance Pharma, Bayer, CALM, Haleon, Kite Pharma, a Gilead Company, Kyowa Kirin, LEO Pharma, the RCN Foundation, Novartis, Santen, Takeda UK and UCB.
No results were found
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...